DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® photodynamic therapy and other products targeting patients with common skin conditions today announced that Bob Doman, President & CEO will present at the Roth Capital Partners Annual New York Institutional Investor Conference.
From: biz.yahoo.com
DUSA Pharmaceuticals to Present at Roth Capital Partners 2007 New York Conference
Posted by Ruslan Abuzant at 6:02 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment